DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fathi AT, DiNardo CD, Kline I. et al.
AG221-C-001 Study Investigators. Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2: analysis of a phase 1/2 study.
JAMA Oncol 2018;
4 (08) 1106-1110
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.